MNMDMind Medicine (MindMed) Inc.

$1B

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$22M

Net Income

-$24M

EPS (Diluted)

$-0.59

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$125M

Total Liabilities

$46M

Stockholders' Equity

$78M

Cash & Equivalents

$100M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$22M	-$14M	-59.7%
Net Income	-$24M	-$5M	-386.7%

MNMD Q4 2023 Earnings — Mind Medicine (MindMed) Inc. Revenue & Financial Results | Market Cap Arena